{
    "2019-06-25": [
        [
            {
                "time": "2019-06-25",
                "original_text": "Health Care Sector Update for 06/25/2019: AGN, GMDA, DERM, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health Care Sector",
                        "AGN",
                        "GMDA",
                        "DERM",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-24",
                "original_text": "Dow Movers: GS, JNJ",
                "features": {
                    "keywords": [
                        "Dow Movers",
                        "GS",
                        "JNJ"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-23",
                "original_text": "Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "JNJ",
                        "Market Dips"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-22",
                "original_text": "Why J&J’s Fallen Stock Is Still Too Pricey",
                "features": {
                    "keywords": [
                        "J&J",
                        "Fallen Stock",
                        "Pricey"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-06-21",
                "original_text": "What Are Analysts Recommending for Johnson & Johnson and Gilead?",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Recommendations",
                        "Johnson & Johnson",
                        "Gilead"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-20",
                "original_text": "How Are Johnson & Johnson’s Revenues Trending in 2019?",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Revenues",
                        "Trending",
                        "2019"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-19",
                "original_text": "Why J&J's Stock May Plunge 10%",
                "features": {
                    "keywords": [
                        "J&J",
                        "Stock",
                        "Plunge",
                        "10%"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-06-18",
                "original_text": "Axsome Initiates Phase III Study on Depression Candidate",
                "features": {
                    "keywords": [
                        "Axsome",
                        "Phase III",
                        "Study",
                        "Depression",
                        "Candidate"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-06-17",
                "original_text": "3 Healthcare Stocks to Buy With the Market Near All-Time Highs",
                "features": {
                    "keywords": [
                        "Healthcare Stocks",
                        "Buy",
                        "Market",
                        "All-Time Highs"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-16",
                "original_text": "What to Expect from Johnson & Johnson and Gilead Sciences’ EPS",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Gilead Sciences",
                        "EPS"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-15",
                "original_text": "An Argus Research Portfolio for Sustainable Impact Stocks",
                "features": {
                    "keywords": [
                        "Argus Research",
                        "Portfolio",
                        "Sustainable Impact Stocks"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}